REATA PHARMACEUTICALS INC Business Finance Contracts & Agreements
21 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (4)
- Registration Rights Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (6)
- Notice of Grant of Restricted Stock Units for employees, dated as of December 2, 2020 (Filed With SEC on May 6, 2021)
- Notice of Grant of Restricted Stock Units for director/consultants, dated as of December 2, 2020 (Filed With SEC on March 1, 2021)
- Underwriting Agreement, dated December 1, 2020, by and among Reata Pharmaceuticals, Inc. and the Representatives (Filed With SEC on December 3, 2020)
- Common Stock Purchase Agreement between the Company and BXLS V River L.P, dated as of June 10, 2020 (Filed With SEC on August 10, 2020)
- Notice of Grant of Restricted Stock Units for employees (Filed With SEC on February 19, 2020)
- Underwriting Agreement, dated November 13, 2019, by and among Reata Pharmaceuticals, Inc. and the Representatives (Filed With SEC on November 14, 2019)
- Notice of Grant of Restricted Stock Units for employees (Filed With SEC on November 12, 2019)
- Restricted Stock Unit Agreement (Filed With SEC on November 12, 2019)
- First Amendment to Amended and Restated Loan and Security Agreement, dated as of October 9, 2019 (Filed With SEC on October 10, 2019)
- Notice of stock option grant forms for employees and director/consultant (Filed With SEC on May 9, 2019)
- Stock Option Agreement (Filed With SEC on May 9, 2019)
- Notice of Stock Option Grant forms for employees and director/consultants (Filed With SEC on February 28, 2019)
- Underwriting Agreement, dated July 24, 2018, by and among Reata Pharmaceuticals, Inc. and the Underwriters named therein (Filed With SEC on July 26, 2018)
- Amended and Restated Loan and Security Agreement, dated as of June 14, 2018, by and among Reata Pharmaceuticals, Inc., as borrower, Oxford Finance LLC, as the collateral agent and... (Filed With SEC on June 14, 2018)
- First Amendment to Loan and Security Agreement, dated as of November 3, 2017, by and among Reata Pharmaceuticals, Inc., as borrower, Oxford Finance LLC, as the collateral agent... (Filed With SEC on November 7, 2017)
- 3,250,000 Shares Class A Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on July 28, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on April 3, 2017)
- Reata Pharmaceuticals, Inc. 5,500,000 Shares Class ACommon Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on May 26, 2016)
- Reata Pharmaceuticals, Inc. [] Shares Class ACommon Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on February 8, 2016)
- REATAPHARMACEUTICALS, INC. SEVENTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 4, 2016)
- REATAPHARMACEUTICALS, INC. EIGHTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on January 4, 2016)
